Parexel’s experts present posters with a range of research and outcomes that impact innovation, value and healthcare decision-making.
View an overview of Parexel’s posters below. Please connect with our authors at ISPOR EU 2026 to find out more or visit us at the event at booth #1218.
ISPOR EU 2026 posters
Economic Evaluation | Health Policy & Regulatory | Health Technology Assessment
Will EU Joint Clinical Assessment (JCA) Reduce "Additional Benefit Not Proven" Outcomes in Germany? Evidence from Recent G-BA Decisions Suggests Persistent, Avoidable Gaps
More
Comparing the Implementation of Outcomes-Based Agreements in Spain and Denmark: Implications for Managing Uncertainty in European Markets
C-Peptide-Based Economic Model for Evaluating Tregs Plus Rituximab in Recent-Onset Type 1 Diabetes
Health Economics and Outcomes Research (HEOR), and Market Access Landscape in China: Uncovering Recent Trends and Potential Implications
Managing MFN Uncertainty: European Responses and Implications for Pricing and Access Strategy
Bridging European and National HTA: Implementation of Joint Clinical Assessments Across EU Member States
Epidemiology & Public Health
Cytomegalovirus Infection in Pediatric Kidney Transplant Recipients Receiving Cytomegalovirus Prophylaxis: A Systematic Literature Review